Conversion of Taxane Glycosides to 10-Deacetylbaccatin III

Jianmin Chen
2004-01-01
Abstract:10-Deacetylbaccatin Ⅲ (10-DAB Ⅲ), the precursor of the anticancer drug taxol and its analogue docetaxel, was obtained by treatment of a mixture of naturally occurring taxane glycosides in a relatively impurified form. The glycoside group of the taxane glycosides was deglycosidated to hydroxyl using periodate and followed hydrazine hydrate. The mixture was then hydrolyzed by hydrazine hydrate and purified through recrystallization. The whole process was monitored by LC/MS/MS. Since the taxane glycosides can be isolated during the process of the production of taxol without influencing on the productivity of the taxol itself, their conversion to 10-DAB Ⅲ improves the total yield of taxol.
What problem does this paper attempt to address?